Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (20)

2022

  1. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  2. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression

    Cancers, Vol. 14, Núm. 4

2021

  1. Identification of a dexamethasone mediated radioprotection mechanism reveals new therapeutic vulnerabilities in glioblastoma

    Cancers, Vol. 13, Núm. 2, pp. 1-23

2017

  1. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681

  2. Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

    Oncogene, Vol. 36, Núm. 19, pp. 2737-2749

2015

  1. Increased gene dosage of ink4/arf and p53 delays age-associated central nervous system functional decline

    Aging Cell, Vol. 14, Núm. 4, pp. 710-714

2012

  1. Oncogenicity of the developmental transcription factor Sox9

    Cancer Research, Vol. 72, Núm. 5, pp. 1301-1315

  2. P27Kip1 directly represses Sox2 during embryonic stem cell differentiation

    Cell Stem Cell, Vol. 11, Núm. 6, pp. 845-852

2009

  1. Anti-aging activity of the Ink4/Arf locus

    Aging Cell, Vol. 8, Núm. 2, pp. 152-161

  2. Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity

    Oncogene, Vol. 28, Núm. 11, pp. 1477-1484

2008

  1. Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice

    Cell, Vol. 135, Núm. 4, pp. 609-622

  2. The Arf/p53 pathway in cancer and aging

    Cancer Research, Vol. 68, Núm. 15, pp. 6031-6034

2007

  1. Delayed ageing through damage protection by the Arf/p53 pathway

    Nature, Vol. 448, Núm. 7151, pp. 375-379

2006

  1. Antiviral action of the tumor suppressor ARF

    EMBO Journal, Vol. 25, Núm. 18, pp. 4284-4292

  2. Specific contribution of p19ARF to nitric oxide-dependent apoptosis

    Journal of Immunology, Vol. 177, Núm. 5, pp. 3327-3336

2005

  1. A strategy to study tyrosinase transgenes in mouse melanocytes

    BMC Cell Biology, Vol. 6

  2. Application of stereocontrolled stepwise [3+2] cycloadditions to the preparation of inhibitors of α4β1-integrin- mediated hepatic melanoma metastasis

    Angewandte Chemie - International Edition, Vol. 44, Núm. 19, pp. 2903-2907

  3. Inactivation of imprinted genes induced by cellular stress and tumorigenesis

    Cancer Research, Vol. 65, Núm. 1, pp. 26-33

  4. Regulation of the INK4a/ARF locus by histone deacetylase inhibitors

    Journal of Biological Chemistry, Vol. 280, Núm. 51, pp. 42433-42441

2004

  1. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging

    Genes and Development, Vol. 18, Núm. 22, pp. 2736-2746